We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.35%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$25.5B
AUM Growth
+$1.27B
(+5.2%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
11.03%
Holding
2,244
New
814
Increased
508
Reduced
495
Closed
411
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$371M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
US Bancorp
USB
|
+$163M |
| 4 |
Lowe's Companies
LOW
|
+$162M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$249M |
| 2 |
Goldman Sachs
GS
|
+$228M |
| 3 |
Alibaba
BABA
|
+$162M |
| 4 |
Cemex
CX
|
+$157M |
| 5 |
Halliburton
HAL
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.75% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 10.26% |
| 4 | Technology | 7.43% |
| 5 | Real Estate | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PUT
Gilead Sciences
GILD
$163B
| $60.8M | 0.24% |
+750,000
| New | +$57.4M |
|
102
Corpay
CPAY
$25.2B
| $60.7M | 0.24% |
391,923
+162,776
| +71% | +$23.9M |
|
103
Builders FirstSource
BLDR
$7.8B
| $60.6M | 0.24% |
3,368,820
+1,433,894
| +74% | +$23.1M |
|
104
General Motors
GM
$76.9B
| $60.1M | 0.24% |
1,488,219
+1,480,619
| +19,482% | +$54.1M |
|
105
Macerich
MAC
$7.34B
| $59.2M | 0.23% |
1,076,145
+689,545
| +178% | +$38.7M |
|
106
AstraZeneca
AZN
$245B
| $58.8M | 0.23% |
868,126
+855,576
| +6,817% | +$54.1M |
|
107
RH
RH
$3.29B
| $58.8M | 0.23% |
835,920
+520,095
| +165% | +$32.6M |
|
108
Armstrong World Industries
AWI
$7.58B
| $56.6M | 0.22% |
1,104,784
+27,072
| +3% | +$1.27M |
|
109
Johnson & Johnson
JNJ
$613B
| $56.6M | 0.22% |
435,257
+382,904
| +731% | +$50.8M |
|
|
TSS
110
DELISTED
Total System Services, Inc.
TSS
| $55.7M | 0.22% |
851,125
+834,476
| +5,012% | +$53.9M |
|
111
CALL
Pfizer
PFE
$143B
| $55.3M | 0.22% |
+1,633,700
| New | +$52.5M |
|
|
PARA
112
DELISTED
Paramount Global Class B
PARA
| $55.3M | 0.22% |
952,948
+704,719
| +284% | +$44.5M |
|
113
Intuitive Surgical
ISRG
$133B
| $55.2M | 0.22% |
474,948
-23,751
| -5% | -$2.59M |
|
114
Restaurant Brands International
QSR
$25.3B
| $54.9M | 0.22% |
859,512
+385,505
| +81% | +$23.8M |
|
|
HPP
115
Hudson Pacific Properties
HPP
$786M
| $54.9M | 0.22% |
233,800
+33,486
| +17% | +$7.62M |
|
116
Cognizant
CTSH
$24.9B
| $54.6M | 0.21% |
752,157
-240,840
| -24% | -$16.9M |
|
|
VR
117
DELISTED
Validus Hold Ltd
VR
| $54.4M | 0.21% |
1,106,007
+1,099,969
| +18,217% | +$55.8M |
|
|
CZR
118
DELISTED
Caesars Entertainment Corporation
CZR
| $54.4M | 0.21% |
4,075,670
+3,330,795
| +447% | +$40.4M |
|
119
Regions Financial
RF
$26.9B
| $53.5M | 0.21% |
3,515,659
-6,628,647
| -65% | -$95.3M |
|
120
Applied Optoelectronics
AAOI
$8.84B
| $53.4M | 0.21% |
825,300
+100,300
| +14% | +$7.09M |
|
121
Northrop Grumman
NOC
$77.9B
| $52.7M | 0.21% |
183,166
+112,687
| +160% | +$30.3M |
|
122
Regency Centers
REG
$14.7B
| $52M | 0.2% |
838,047
+592,494
| +241% | +$38.2M |
|
123
Ulta Beauty
ULTA
$23B
| $52M | 0.2% |
229,919
+139,145
| +153% | +$33.5M |
|
124
Zimmer Biomet
ZBH
$18.8B
| $51.9M | 0.2% |
456,701
-327,600
| -42% | -$37.8M |
|
125
Southern Company
SO
$107B
| $51.8M | 0.2% |
1,054,469
+919,892
| +684% | +$44.6M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Balyasny Asset Management held 2,244 positions worth $25.5B, up 5.2% from $24.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management's Q3 2017 filing shows 814 new, 508 increased, 495 reduced and 411 closed positions. Its largest new stake was Range Resources: 5,316,064 shares worth $104M. The largest sale was Bank of America, an estimated $249M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Balyasny Asset Management's largest Q3 2017 buy was Range Resources: 5,316,064 shares worth $104M.
- Balyasny Asset Management added most to JPMorgan Chase in Q3 2017, an estimated $371M increase.
- Balyasny Asset Management's biggest Q3 2017 reduction was Bank of America, cutting an estimated $249M.
- Balyasny Asset Management fully exited Cemex in Q3 2017, selling an estimated $157M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $25.5B portfolio in Q3 2017.
- Balyasny Asset Management opened 814 new positions and closed 411 in Q3 2017.
- Balyasny Asset Management's portfolio value rose 5.2% quarter-over-quarter to $25.5B.
Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.